Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination.
Huynh T, Birkhead J, Huber K, O'Loughlin J, Stenestrand U, Weston C, Jernberg T, Schull M, Welsh RC, Denktas AE, Travers A, Sookram S, Theroux P, Tu JV, Timmis A, Smalling R, Danchin N. Huynh T, et al. Among authors: theroux p. JACC Cardiovasc Interv. 2011 Aug;4(8):877-83. doi: 10.1016/j.jcin.2011.05.013. JACC Cardiovasc Interv. 2011. PMID: 21851902 Free article.
Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.
Huynh T, Perron S, O'Loughlin J, Joseph L, Labrecque M, Tu JV, Théroux P. Huynh T, et al. Among authors: theroux p. Circulation. 2009 Jun 23;119(24):3101-9. doi: 10.1161/CIRCULATIONAHA.108.793745. Epub 2009 Jun 8. Circulation. 2009. PMID: 19506117
Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
Huynh T, Nasmith J, Luong TM, Bernier M, Pharand C, Xue-Qiao Z, Giugliano RP, Theroux P. Huynh T, et al. Among authors: theroux p. Can J Cardiol. 2009 Dec;25(12):e417-21. doi: 10.1016/s0828-282x(09)70536-7. Can J Cardiol. 2009. PMID: 19960136 Free PMC article.
Assessment and management of acute coronary syndromes (ACS): a Canadian perspective on current guideline-recommended treatment--part 2: ST-segment elevation myocardial infarction.
Fitchett DH, Theroux P, Brophy JM, Cantor WJ, Cox JL, Gupta M, Kertland H, Mehta SR, Welsh RC, Goodman SG. Fitchett DH, et al. Among authors: theroux p. Can J Cardiol. 2011 Nov-Dec;27 Suppl A:S402-12. doi: 10.1016/j.cjca.2011.08.107. Can J Cardiol. 2011. PMID: 22118043 Review.
Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
Huynh T, Theroux P, Snapinn S, Wan Y; Montreal General Hospital, Montreal, Quebec, Canada. [email protected]. Huynh T, et al. Among authors: theroux p. Am Heart J. 2003 Oct;146(4):668-73. doi: 10.1016/S0002-8703(03)00255-2. Am Heart J. 2003. PMID: 14564321 Clinical Trial.
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.
Bell AD, Roussin A, Cartier R, Chan WS, Douketis JD, Gupta A, Kraw ME, Lindsay TF, Love MP, Pannu N, Rabasa-Lhoret R, Shuaib A, Teal P, Théroux P, Turpie AG, Welsh RC, Tanguay JF. Bell AD, et al. Among authors: theroux p. Can J Cardiol. 2011 Mar-Apr;27(2):208-21. doi: 10.1016/j.cjca.2010.12.033. Can J Cardiol. 2011. PMID: 21459270 Review.
339 results